게시물
A major pharmaceutical company has been accused of tampering with clinical trial data for a drug worth $3.7 billion. Patients are reportedly dying from liver failure, and the FDA has recommended an immediate withdrawal. However, Amgen is pushing back. The story began in 2021, when a small biotech firm called ChemoCentryx was involved. Here is the full thread:
2mo
10 좋아요0 싫어요5 리포스트10 댓글
?
댓글
아직 댓글이 없습니다. 첫 댓글을 남겨보세요!